Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Juan Hormazabal"'
Autor:
Maria Cecilia Poli, Cecilia Vial, Emma Rey-Jurado, Natalia González, Lina Jimena Cortés, Juan Hormazabal, Carolina Ramírez-Riffo, Javiera de la Cruz, Camilo Ulloa
Publikováno v:
Vaccines, Vol 11, Iss 5, p 1012 (2023)
Chronic kidney disease (CKD) patients have an increased risk of morbidity and mortality following SARS-CoV-2 infection. Vaccination in these patients is prioritized, and monitoring of the immune response is paramount to define further vaccination str
Externí odkaz:
https://doaj.org/article/2f9e9c367ede42e9a9928e40a1ac26ba
Autor:
Alejandro Escobar, Felipe E. Reyes-López, Mónica L. Acevedo, Luis Alonso-Palomares, Fernando Valiente-Echeverría, Ricardo Soto-Rifo, Hugo Portillo, Jimena Gatica, Ivan Flores, Estefanía Nova-Lamperti, Carlos Barrera-Avalos, María Rosa Bono, Leonardo Vargas, Valeska Simon, Elias Leiva-Salcedo, Cecilia Vial, Juan Hormazabal, Lina Jimena Cortes, Daniel Valdés, Ana M. Sandino, Mónica Imarai, Claudio Acuña-Castillo
Publikováno v:
Frontiers in Immunology, Vol 12 (2022)
CoronaVac vaccine from Sinovac Life Science is currently being used in several countries. In Chile, the effectiveness of preventing hospitalization is higher than 80% with a vaccination schedule. However, to date, there are no data about immune respo
Externí odkaz:
https://doaj.org/article/567bda70ec194d8aa689dad8556c9e4f
Autor:
Fernando Ormeño, Juan Hormazabal, José Moreno, Felipe Riquelme, Javiera Rios, Alfredo Criollo, Amelina Albornoz, Iván E. Alfaro, Mauricio Budini
Publikováno v:
Frontiers in Molecular Neuroscience, Vol 13 (2020)
TAR DNA binding protein 43 kDa (TDP-43) is a ribonuclear protein regulating many aspects of RNA metabolism. Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Lobar Degeneration (FTLD) are fatal neurodegenerative diseases with the presence of TDP
Externí odkaz:
https://doaj.org/article/fefdbe6854704464b5f013f09ed4ef22
SARS-CoV-2 Neutralizing Antibodies in Chile after a Vaccination Campaign with Five Different Schemes
Autor:
Ximena Aguilera, Juan Hormazabal, Cecilia Vial, Lina Jimena Cortes, Claudia Gonzalez, Paola Rubilar, Mauricio Apablaza, Muriel Ramirez-Santana, Gloria Icaza, Loreto Nuñez-Franz, Carla Castillo-Laborde, Carolina Ramirez-Riffo, Claudia Perez, Ruben Quezada-Gate, Macarena Said, Pablo Vial
Publikováno v:
Vaccines. 10(7)
Using levels of neutralizing antibodies (nAbs), we evaluate the successful Chilean SARS-CoV-2 vaccine campaign, which combines different vaccine technologies and heterologous boosters. From a population-based study performed in November 2021, we rand
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d42097148faa07afd8bb920e717130e1
https://pubmed.ncbi.nlm.nih.gov/35891215
https://pubmed.ncbi.nlm.nih.gov/35891215
Autor:
Emma Rey-Jurado, Yazmin Espinosa, Camila Astudillo, Lina Jimena Cortés, Juan Hormazabal, Loreani P. Noguera, Fernanda Cofré, Cecilia Piñera, Ricardo González, Alexander Bataszew, Paula Muñoz Venturelli, Dona Benadof, Patricia Álvarez, Valeria Acevedo, Pablo Vial, Cecilia Vial, M. Cecilia Poli
Publikováno v:
Journal of Allergy and Clinical Immunology. 150:1074-1085.e11
Multisystemic inflammatory syndrome in children (MIS-C) is a life-threatening disease that occurs 2-5 weeks after severe acute respiratory syndrome coronavirus 2 exposure and is characterized by severe multisystemic inflammation. Early recognition of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b6cad4e749130d43452caae20e50fe8
https://doi.org/10.1016/j.jaci.2022.09.006
https://doi.org/10.1016/j.jaci.2022.09.006
Autor:
Aldo Barrera, Constanza Martínez-Valdebenito, Jenniffer Angulo, Carlos Palma, Juan Hormazábal, Cecilia Vial, Ximena Aguilera, Pablo Castillo-Torres, Catalina Pardo-Roa, María Elvira Balcells, Bruno Nervi, Nicole Le Corre, Marcela Ferrés
Publikováno v:
Frontiers in Medicine, Vol 11 (2024)
Since the SARS-CoV-2 outbreak in 2019, a diversity of viral genomic variants has emerged and spread globally due to increased transmissibility, pathogenicity, and immune evasion. By the first trimester of 2023 in Chile, as in most countries, BQ and X
Externí odkaz:
https://doaj.org/article/7936f3a4f97f4553960bdc4f7a1f5514
Autor:
Juan Hormazabal Opazo, Alvaro Flores Andrade, Esteban Alfredo Paredes-Osses, Alda Fernandez Ricci, María Cristina Martínez Hernández, Sergio Duarte Boke, Marcelo Ulloa Bello, Pamela Araya Rodriguez, Kimberly Espinoza Aguilar, Alejandra Vaquero Orellana
Publikováno v:
Revista del Instituto de Salud Pública de Chile. 4
Salmonella enterica es uno de los microorganismos transmitidos por alimentos más significativos a nivel global. Los últimos reportes han mencionado que Salmonella enterica subsp. enterica serovar Infantis (S. Infantis) se ha convertido en un releva
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c12eacb569cdd9d38d16eb2d9f7a56b3
https://doi.org/10.34052/rispch.v4i2.112
https://doi.org/10.34052/rispch.v4i2.112
Autor:
Juan Hormazábal, Loreto Nuñez-Franz, Paola Rubilar, Mauricio Apablaza, Cecilia Vial, Lina Jimena Cortés, Natalia González, Pablo Vial, Macarena Said, Claudia González, Kathya Olivares, Ximena Aguilera, Muriel Ramírez-Santana
Publikováno v:
Vaccine: X, Vol 15, Iss , Pp 100372- (2023)
Objective: The study compared immunity to the original SARS-CoV-2 virus (Wuhan) and the Omicron variant using neutralizing antibodies (NAbs), that provide a good approximation of protective immunity. The results might help determine immunization stra
Externí odkaz:
https://doaj.org/article/ea7528395f634e6fb13e28b9d2e42c20
Autor:
Loreto Núñez-Franz, Muriel Ramírez-Santana, Paola Rubilar, Cecilia Vial, Mauricio Apablaza, Claudia González, Macarena Said, Kathya Olivares, Lina Jimena Cortés, Juan Hormazábal, Luis Canales, Pablo Vial, Gloria Icaza, Rubén Quezada-Gaete, Ximena Aguilera
Publikováno v:
Viruses, Vol 15, Iss 1, p 201 (2023)
Background: Chile has achieved the highest coverage for vaccines against the SARS-CoV-2 virus worldwide. Objective: To assess the progression of immunity (natural and acquired by vaccine) in a cohort from two Chilean cities. Methods: Individuals (n =
Externí odkaz:
https://doaj.org/article/1607ff752aa24e119705ca9850db81ec
Autor:
Ximena Aguilera, Claudia González, Mauricio Apablaza, Paola Rubilar, Gloria Icaza, Muriel Ramírez-Santana, Claudia Pérez, Lina Jimena Cortes, Loreto Núñez-Franz, Rubén Quezada-Gaete, Carla Castillo-Laborde, Juan Correa, Macarena Said, Juan Hormazábal, Cecilia Vial, Pablo Vial
Publikováno v:
Vaccines, Vol 10, Iss 7, p 1002 (2022)
Chile is among the most successful nations worldwide in terms of its COVID-19 vaccine rollout. By 31 December 2021, 84.1% of the population was fully vaccinated, and 56.1% received booster doses using different COVID-19 vaccines. In this context, we
Externí odkaz:
https://doaj.org/article/af01ab779dd84578ac11fd680fd14ab4